Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||||
| Cash income from operating activities | 0.00%50K | 50K | |||||
| Other cash income from operating activities | ---- | ---- | ---- | ---- | 0.00%50K | --50K | ---- |
| Cash paid | 26.61%-3.73M | 61.08%-5.08M | 55.30%-13.04M | -194.02%-29.18M | -155.58%-9.92M | 41.26%-3.88M | -6.61M |
| Payments to suppliers for goods and services | -15.79%-1.92M | 23.52%-1.66M | -12.95%-2.17M | -20.39%-1.92M | -31.86%-1.59M | -80.76%-1.21M | ---668.59K |
| Other cash payments from operating activities | 47.17%-1.81M | 68.56%-3.42M | 60.11%-10.88M | -227.23%-27.26M | -211.48%-8.33M | 54.99%-2.67M | ---5.94M |
| Direct interest paid | 49.13%-12.32K | 51.46%-24.22K | 0.25%-49.88K | -46.70%-50.01K | 34.33%-34.09K | ---51.91K | ---- |
| Direct interest received | 65.83%17.94K | -38.55%10.82K | 1,505.84%17.6K | 49.73%1.1K | -15.57%732 | -97.83%867 | --39.92K |
| Operating cash flow | 26.92%-3.72M | 61.07%-5.09M | 55.27%-13.08M | -195.01%-29.23M | -155.08%-9.91M | 40.88%-3.88M | ---6.57M |
| Investing cash flow | |||||||
| Cash flow from continuing investing activities | -333.66%-243.6K | 102.95%104.25K | -602.83%-3.54M | -88.21%-503.1K | 63.79%-267.31K | -202.97%-738.31K | -243.69K |
| Capital expenditure reported | ---- | ---- | ---- | ---- | ---- | ---729.67K | ---- |
| Net PPE purchase and sale | -459.11%-214.22K | 101.98%59.65K | -495.76%-3.01M | -311.47%-504.48K | -1,318.38%-122.61K | 92.56%-8.64K | ---116.18K |
| Net intangibles purchas and sale | ---- | ---- | ---529.93K | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | -165.87%-29.38K | 4,206.63%44.6K | -178.75%-1.09K | 100.95%1.38K | ---144.7K | ---- | ---127.51K |
| Net other investing changes | ---- | ---- | ---- | 100.95%1.38K | ---144.7K | ---- | ---- |
| Cash from discontinued investing activities | |||||||
| Investing cash flow | -333.66%-243.6K | 102.95%104.25K | -602.83%-3.54M | -88.21%-503.1K | 63.79%-267.31K | -202.97%-738.31K | ---243.69K |
| Financing cash flow | |||||||
| Cash flow from continuing financing activities | -66.83%1.95M | -23.56%5.87M | -75.18%7.68M | 65.32%30.93M | 477.08%18.71M | 82.55%3.24M | 1.78M |
| Net issuance payments of debt | -140.59%-405.87K | -49.81%1M | 19,039.55%1.99M | -2.89%-10.52K | -100.63%-10.23K | 14,136.19%1.62M | ---11.51K |
| Net common stock issuance | -52.79%2.39M | -14.58%5.07M | -80.95%5.94M | 65.29%31.15M | 991.29%18.85M | -3.37%1.73M | --1.79M |
| Net other financing activities | 89.75%-41.23K | 19.80%-402.18K | -17.46%-501.49K | -65.45%-426.93K | -28.26%-258.04K | ---201.18K | ---- |
| Cash from discontinued financing activities | |||||||
| Financing cash flow | -66.83%1.95M | -23.56%5.87M | -75.18%7.68M | 65.32%30.93M | 477.08%18.71M | 82.55%3.24M | --1.78M |
| Net cash flow | |||||||
| Beginning cash position | 39.37%3.12M | -79.80%2.24M | 21.43%11.07M | 1,696.04%9.12M | -72.99%507.75K | -72.34%1.88M | --6.8M |
| Current changes in cash | -328.50%-2.02M | 109.88%882.8K | -845.65%-8.93M | -85.96%1.2M | 718.15%8.53M | 72.60%-1.38M | ---5.04M |
| Effect of exchange rate changes | 651.26%13.09K | -102.46%-2.37K | -87.24%96.51K | 871.19%756.41K | 827.20%77.89K | -93.15%8.4K | --122.55K |
| End cash Position | -64.30%1.11M | 39.37%3.12M | -79.80%2.24M | 21.43%11.07M | 1,696.04%9.12M | -72.99%507.75K | --1.88M |
| Free cash from | 22.69%-4.03M | 68.58%-5.22M | 44.13%-16.61M | -196.43%-29.73M | -116.99%-10.03M | 30.87%-4.62M | ---6.69M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |